KW-6002 (istradefylline)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for KW-6002 (istradefylline), covering 2012-08-29 to 2013-06-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa [Phase 3]